{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:38:11Z","timestamp":1761237491642},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.nbd.2007.11.003","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T21:50:57Z","timestamp":1196805057000},"page":"446-455","source":"Crossref","is-referenced-by-count":19,"title":["Unexpected off-targeting effects of anti-huntingtin ribozymes and siRNA in vivo"],"prefix":"10.1016","volume":"29","author":[{"given":"Eileen M.","family":"Denovan-Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgardo","family":"Rodriguez-Lebron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred S.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2007.11.003_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2007.11.003_bib2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1095\/biolreprod49.4.816","article-title":"Tissue distribution of alpha 1-proteinase inhibitor messenger ribonucleic acid and its regulation by glucocorticoids in fetal and neonatal sheep","volume":"49","author":"Berdusco","year":"1993","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.nbd.2007.11.003_bib3","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.nbd.2007.11.003_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nmeth854","article-title":"3' UTR seed matches, but not overall identity, are associated with RNAi off-targets","volume":"3","author":"Birmingham","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.nbd.2007.11.003_bib4","first-page":"239","article-title":"Antisense-mediated down-regulation of the human huntingtin gene","volume":"295","author":"Boado","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2007.11.003_bib5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1112014","article-title":"The transcriptional landscape of the mammalian genome","volume":"309","author":"Carninci","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2007.11.003_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.nbd.2007.11.003_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2007.11.003_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2005.02.024","article-title":"Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference","volume":"329","author":"Chen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2007.11.003_bib9","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington's disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.11.003_bib11","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.11.003_bib10","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.11.003_bib12","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.11.003_bib13","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.11.003_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2007.11.003_bib15","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2007.11.003_bib16","doi-asserted-by":"crossref","unstructured":"Hasholt, L., et al., 2003. Antisense downregulation of mutant huntingtin in a cell model: inhibition of Huntington synthesis by antisense oligodeoxynucleotides: antisense-mediated down-regulation of the human huntingtin gene. J. Gene Med.: Mol. Cell Neurosci: J. Pharmacol. Exp. Ther. 5. 16. 295, 528\u201338, 313\u201323, 239\u201343.","DOI":"10.1002\/jgm.378"},{"key":"10.1016\/j.nbd.2007.11.003_bib17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2007.11.003_bib48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm1191","article-title":"Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7","volume":"11","author":"Hornung","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2007.11.003_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tig.2004.08.006","article-title":"Noise amidst the silence: off-target effects of siRNAs?","volume":"20","author":"Jackson","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2007.11.003_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2007.11.003_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2007.11.003_bib21","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.1112009","article-title":"Antisense transcription in the mammalian transcriptome","volume":"309","author":"Katayama","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2007.11.003_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt940","article-title":"Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase","volume":"22","author":"Kim","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2007.11.003_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0005-2744(81)90217-5","article-title":"Ontogeny and tissue distribution of alpha-1-antitrypsin of the mouse","volume":"662","author":"Lamontagne","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2007.11.003_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin\u2013protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2007.11.003_bib25","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1093\/nar\/gki762","article-title":"siRNA-mediated off-target gene silencing triggered by a 7 nt complementation","volume":"33","author":"Lin","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2007.11.003_bib26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2007.11.003_bib27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jnr.10100","article-title":"Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice","volume":"67","author":"MacGibbon","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2007.11.003_bib28","first-page":"482","article-title":"Clinical trials in neurological disorders using AAV vectors: promises and challenges","volume":"6","author":"Mandel","year":"2004","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.nbd.2007.11.003_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease","volume":"162","author":"Menalled","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2007.11.003_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mcne.2000.0872","article-title":"Inhibition of Huntington synthesis by antisense oligodeoxynucleotides","volume":"16","author":"Nellemann","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2007.11.003_bib31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbrc.2005.10.061","article-title":"siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitro","volume":"338","author":"Omi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2007.11.003_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2007.11.003_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2004.08.096","article-title":"Double-stranded siRNA targeted to the huntingtin gene does not induce DNA methylation","volume":"323","author":"Park","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2007.11.003_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2007.11.003_bib35","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/hmg\/4.8.1365","article-title":"Expression of the Huntington's disease (IT15) protein product in HD patients","volume":"4","author":"Schilling","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2007.11.003_bib36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","article-title":"Widespread expression of Huntington's disease gene (IT15) protein product","volume":"14","author":"Sharp","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2007.11.003_bib37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1038","article-title":"Activation of the interferon system by short-interfering RNAs","volume":"5","author":"Sledz","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2007.11.003_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2007.11.003_bib39","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.11.003_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","article-title":"Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA","volume":"53","author":"Wang","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2007.11.003_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2007.11.003_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/1531-8249(199909)46:3<366::AID-ANA12>3.0.CO;2-D","article-title":"Sequence-specific cleavage of Huntingtin mRNA by catalytic DNA","volume":"46","author":"Yen","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2007.11.003_bib43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1261\/rna.7233305","article-title":"Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs","volume":"11","author":"Yi","year":"2005","journal-title":"RNA"},{"key":"10.1016\/j.nbd.2007.11.003_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0162-0134(00)00005-2","article-title":"Chemical and enzymatic probing of effector-mediated changes in the conformation of a maxizyme","volume":"78","author":"Zhou","year":"2000","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.nbd.2007.11.003_bib45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2007.11.003_bib46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107002495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107002495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T10:56:09Z","timestamp":1557053769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996107002495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0969996107002495"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2007.11.003","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}